Equities

Instituto de Diagnostico SA

INDISA:SGO

Instituto de Diagnostico SA

Actions
Health CareHealth Care Providers
  • Price (CLP)1,400.00
  • Today's Change0.00 / 0.00%
  • Shares traded13.52k
  • 1 Year change+5.18%
  • Beta0.6586
Data delayed at least 20 minutes, as of Sep 13 2024 17:29 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CLP
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments12,76314,18910,067
Total Receivables, Net83,84781,04472,858
Total Inventory3,0243,6642,705
Prepaid expenses------
Other current assets, total--356586
Total current assets99,63499,25386,217
Property, plant & equipment, net153,735153,471130,642
Goodwill, net------
Intangibles, net8,3645,9963,055
Long term investments8,0288,8178,217
Note receivable - long term4,4184,70146
Other long term assets353330628
Total assets276,575272,965230,876
LIABILITIES
Accounts payable29,05519,67217,036
Accrued expenses1,5871,4921,180
Notes payable/short-term debt000
Current portion long-term debt/capital leases29,52231,99245,279
Other current liabilities, total28,58035,20032,395
Total current liabilities88,74388,35695,890
Total long term debt82,50780,82739,672
Total debt112,029112,81984,951
Deferred income tax01,711--
Minority interest------
Other liabilities, total1,305370148
Total liabilities172,555171,264135,710
SHAREHOLDERS EQUITY
Common stock59,57859,57859,578
Additional paid-in capital------
Retained earnings (accumulated deficit)44,44242,12335,588
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity104,020101,70195,166
Total liabilities & shareholders' equity276,575272,965230,876
Total common shares outstanding141141141
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.